Actionable news
All posts from Actionable news
Actionable news in GBT: Global Blood Therapeutics Inc,

18 Biggest Mid-Day Gainers For Wednesday

  • Evoke Pharma Inc EVOK 30.43% shares jumped 27 percent to $2.63. Evoke Pharma disclosed that Phase 3 Gimoti trial failed to reach its primary endpoint. However, the company announced that 51 percent of patients responded better to Gimoti than placebo.
Mar 2016JMP SecuritiesDowngradesMarket OutperformMarket Perform
Feb 2016RBC CapitalDowngradesOutperformSector Perform
Feb 2016JP MorganDowngradesOverweightNeutral

© 2017 Benzinga does not provide investment advice. All rights reserved.